Work

Supplementary Table S1 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table S1 from Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors

DOI: 10.1158/1535-7163.22484711.v1

Authors: Richard D. Baird, Jos Kitzen, Paul A. Clarke, Andre Planting, Sarah Reade, Alison Reid, Lyndsey Welsh, Luis López Lázaro, Begona de las Heras, Ian R. Judson, Stan B. Kaye, Ferry Eskens, Paul Workman, Johann S. deBono, Jaap Verweij

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361961859

Cites:

Cited by:

Related to: 10